SEATTLE — In this Healio Video Perspective from the ASRS annual meeting, Durga Borkar, MD, MMCi, discusses the FARETINA-DME study investigating real-world outcomes of faricimab treatment in diabetic macular edema.
Data were collected from the IRIS Registry and included patients with DME who were treated with at least one faricimab injection between February and September 2022.
Borkar highlights the observed improvements in visual acuity and the extension of treatment intervals.
“FARETINA-DME is the largest ongoing real-world data study of diabetic macular edema patients utilizing